SANA - Sana Biotechnology, Inc.
NEXT EARNINGS:
Mar 16, 2026
(in 19 days)
EPS Est: $-0.12
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$8.00
DETAILS
HIGH:
$8.00
LOW:
$8.00
MEDIAN:
$8.00
CONSENSUS:
$8.00
UPSIDE:
89.13%
Market Cap:
1.13B
Volume:
1,348,878
Avg Volume:
3,523,505
52 Week Range:
1.26-6.55
Sector:
Healthcare
Industry:
Biotechnology
Beta:
1.97
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
194
IPO Date:
2021-02-04
EPS (TTM):
-1.16
P/E Ratio:
-1.41
Revenue (TTM):
N/A
Total Assets:
501.02M
Total Debt:
94.20M
Cash & Equiv:
127.57M
Rev Growth (5Y):
N/A
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-59.9%
Debt/Equity:
0.38
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-06 | $-0.15 | $-0.18 | +16.7% | — | — | — |
| 2025-08-11 | $-0.16 | $-0.20 | +20.0% | — | — | — |
| 2025-05-08 | $-0.20 | $-0.22 | +9.1% | — | — | — |
| 2025-03-17 | $-0.23 | $-0.25 | +8.0% | — | — | — |
| 2024-11-08 | $-0.25 | $-0.26 | +3.8% | — | — | — |
| 2024-08-08 | $-0.32 | $-0.27 | -18.5% | — | — | — |
| 2024-05-08 | $-0.32 | $-0.30 | -6.7% | — | — | — |
| 2024-02-29 | $-0.35 | $-0.37 | +5.4% | — | — | — |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | (266.76M) | (283.25M) | (269.48M) | (355.93M) | (285.31M) | (130.78M) | (13.25M) |
| EPS | -1.16 | -1.46 | -1.43 | -2.14 | -1.63 | -0.70 | -0.07 |
| Total Assets | 501.02M | 565.30M | 822.72M | 1.13B | 730.30M | 415.19M | 34.33M |
| Total Debt | 94.20M | 104.10M | 108.25M | 110.94M | 71.91M | 47.70M | 0 |
| Cash & Equivalents | 127.57M | 133.52M | 176.76M | 253.03M | 124.81M | 80.03M | 30.63M |
| Operating Cash Flow | (223.15M) | (253.58M) | (290.05M) | (251.05M) | (137.98M) | (85.50M) | (13.49M) |
| Free Cash Flow | (256.58M) | (273.61M) | (310.93M) | (280.92M) | (161.85M) | (111.69M) | (13.96M) |
| FCF per Share | -1.11 | -1.41 | -1.65 | -1.69 | -0.86 | -0.60 | -0.07 |
| Book Value | 250.50M | 287.51M | 499.31M | 728.50M | (421.18M) | (142.54M) | (13.19M) |
| Cash & ST Investments | 152.50M | 205.19M | 423.96M | 551.00M | 378.26M | 138.98M | 30.63M |
| ROC Equity | -1.06 | -0.99 | -0.54 | -0.49 | N/A | N/A | N/A |